对石仓浩的回复。可溶性C型凝集素样受体2（sCLEC-2）×D-二聚体/血小板（PLT）（sCLEC-2×D-二聚体/PLT）对凝血/纤溶状态意味着什么？对“山本等人。使用可溶性C型凝集素样受体2诊断弥散性血管内凝血的超级公式。2023年，，2299”的评论。
Reply to Ishikura, H. What Does Soluble C-Type Lectin-like Receptor 2 (sCLEC-2) × D-Dimer/Platelet (PLT) (sCLEC-2 × D-Dimer/PLT) Mean for Coagulation/Fibrinolysis Conditions? Comment on "Yamamoto et al. Super Formula for Diagnosing Disseminated Intravascular Coagulation Using Soluble C-Type Lectin-like Receptor 2. 2023, , 2299".
作者信息
Wada Hideo, Yamamoto Akitaka, Shiraki Katsuya, Shimpo Hideto
机构信息
Department of General and Laboratory Medicine, Mie Prefectural General Medical Center, Yokkaichi 510-8561, Japan.
Department of Emergency and Critical Care Center, Mie Prefectural General Medical Center, Yokkaichi 510-8561, Japan.
出版信息
Diagnostics (Basel). 2023 Dec 25;14(1):42. doi: 10.3390/diagnostics14010042.
Abstract
We would like to thank Dr. Ishikura for his kind comment [...].
摘要
我们要感谢石仓博士的友好评论[...]。
相似文献
1
Reply to Ishikura, H. What Does Soluble C-Type Lectin-like Receptor 2 (sCLEC-2) × D-Dimer/Platelet (PLT) (sCLEC-2 × D-Dimer/PLT) Mean for Coagulation/Fibrinolysis Conditions? Comment on "Yamamoto et al. Super Formula for Diagnosing Disseminated Intravascular Coagulation Using Soluble C-Type Lectin-like Receptor 2. 2023, , 2299".对石仓浩的回复。可溶性C型凝集素样受体2（sCLEC-2）×D-二聚体/血小板（PLT）（sCLEC-2×D-二聚体/PLT）对凝血/纤溶状态意味着什么？对“山本等人。使用可溶性C型凝集素样受体2诊断弥散性血管内凝血的超级公式。2023年，，2299”的评论。
Diagnostics (Basel). 2023 Dec 25;14(1):42. doi: 10.3390/diagnostics14010042.
2
What Does Soluble C-Type Lectin-like Receptor 2 (sCLEC-2) × D-Dimer/Platelet (PLT) (sCLEC-2 × D-Dimer/PLT) Mean for Coagulation/Fibrinolysis Conditions? Comment on Yamamoto et al. Super Formula for Diagnosing Disseminated Intravascular Coagulation Using Soluble C-Type Lectin-like Receptor 2. 2023, , 2299.可溶性C型凝集素样受体2（sCLEC-2）×D-二聚体/血小板（PLT）（sCLEC-2×D-二聚体/PLT）对凝血/纤溶状态意味着什么？对山本等人的评论。使用可溶性C型凝集素样受体2诊断弥散性血管内凝血的超级公式。2023年，，2299。
Diagnostics (Basel). 2023 Dec 25;14(1):41. doi: 10.3390/diagnostics14010041.
3
Super Formula for Diagnosing Disseminated Intravascular Coagulation Using Soluble C-Type Lectin-like Receptor 2.利用可溶性C型凝集素样受体2诊断弥散性血管内凝血的超级公式
Diagnostics (Basel). 2023 Jul 6;13(13):2299. doi: 10.3390/diagnostics13132299.
4
Detection of Thrombosis Using Soluble C-Type Lectin-like Receptor-2 with D-Dimer Level and Platelet Count.利用可溶性C型凝集素样受体-2结合D-二聚体水平和血小板计数检测血栓形成
J Clin Med. 2024 Oct 8;13(19):5980. doi: 10.3390/jcm13195980.
5
Super Formula for Soluble C-Type Lectin-Like Receptor 2 × D-Dimer in Patients With Acute Cerebral Infarction.可溶性 C 型凝集素样受体 2×D-二聚体在急性脑梗死患者中的超公式。
Clin Appl Thromb Hemost. 2024 Jan-Dec;30:10760296241232858. doi: 10.1177/10760296241232858.
6
Soluble C-Type Lectin-Like Receptor 2 Is a Biomarker for Disseminated Intravascular Coagulation.可溶性C型凝集素样受体2是弥散性血管内凝血的生物标志物。
J Clin Med. 2021 Jun 28;10(13):2860. doi: 10.3390/jcm10132860.
7
Early recognition of sepsis-induced coagulopathy using the C2PAC index: a ratio of soluble type C lectin-like receptor 2 (sCLEC-2) level and platelet count.采用 C2PAC 指数早期识别脓毒症诱导的凝血功能障碍：可溶性 C 型凝集素样受体 2（sCLEC-2）水平与血小板计数的比值。
Platelets. 2022 Aug 18;33(6):935-944. doi: 10.1080/09537104.2021.2019694. Epub 2022 Jan 24.
8
Soluble C-Type Lectin-Like Receptor 2 Elevation in Patients with Acute Cerebral Infarction.急性脑梗死患者可溶性C型凝集素样受体2升高
J Clin Med. 2021 Jul 30;10(15):3408. doi: 10.3390/jcm10153408.
9
Measurement of soluble C-type lectin-like receptor 2 in human plasma.人血浆中可溶性C型凝集素样受体2的检测
Platelets. 2015;26(8):711-9. doi: 10.3109/09537104.2015.1021319. Epub 2015 Apr 9.
10
Elevated ratio of C-type lectin-like receptor 2 level and platelet count (C2PAC) aids in the diagnosis of post-operative venous thromboembolism in IDH-wildtype gliomas.C 型凝集素样受体 2 水平与血小板计数比值（C2PAC）升高有助于 IDH 野生型脑胶质瘤术后静脉血栓栓塞症的诊断。
Thromb Res. 2023 Mar;223:36-43. doi: 10.1016/j.thromres.2023.01.018. Epub 2023 Jan 21.
引用本文的文献
1
Super Formula for Soluble C-Type Lectin-Like Receptor 2 × D-Dimer in Patients With Acute Cerebral Infarction.可溶性 C 型凝集素样受体 2×D-二聚体在急性脑梗死患者中的超公式。
Clin Appl Thromb Hemost. 2024 Jan-Dec;30:10760296241232858. doi: 10.1177/10760296241232858.
本文引用的文献
1
What Does Soluble C-Type Lectin-like Receptor 2 (sCLEC-2) × D-Dimer/Platelet (PLT) (sCLEC-2 × D-Dimer/PLT) Mean for Coagulation/Fibrinolysis Conditions? Comment on Yamamoto et al. Super Formula for Diagnosing Disseminated Intravascular Coagulation Using Soluble C-Type Lectin-like Receptor 2. 2023, , 2299.可溶性C型凝集素样受体2（sCLEC-2）×D-二聚体/血小板（PLT）（sCLEC-2×D-二聚体/PLT）对凝血/纤溶状态意味着什么？对山本等人的评论。使用可溶性C型凝集素样受体2诊断弥散性血管内凝血的超级公式。2023年，，2299。
Diagnostics (Basel). 2023 Dec 25;14(1):41. doi: 10.3390/diagnostics14010041.
2
Super Formula for Diagnosing Disseminated Intravascular Coagulation Using Soluble C-Type Lectin-like Receptor 2.利用可溶性C型凝集素样受体2诊断弥散性血管内凝血的超级公式
Diagnostics (Basel). 2023 Jul 6;13(13):2299. doi: 10.3390/diagnostics13132299.
3
Elevated ratio of C-type lectin-like receptor 2 level and platelet count (C2PAC) aids in the diagnosis of post-operative venous thromboembolism in IDH-wildtype gliomas.C 型凝集素样受体 2 水平与血小板计数比值（C2PAC）升高有助于 IDH 野生型脑胶质瘤术后静脉血栓栓塞症的诊断。
Thromb Res. 2023 Mar;223:36-43. doi: 10.1016/j.thromres.2023.01.018. Epub 2023 Jan 21.
4
Elevated Plasma Soluble C-Type Lectin-like Receptor 2 Is Associated with the Worsening of Coronavirus Disease 2019.血浆可溶性C型凝集素样受体2升高与2019冠状病毒病病情恶化相关。
J Clin Med. 2022 Feb 14;11(4):985. doi: 10.3390/jcm11040985.
5
Early recognition of sepsis-induced coagulopathy using the C2PAC index: a ratio of soluble type C lectin-like receptor 2 (sCLEC-2) level and platelet count.采用 C2PAC 指数早期识别脓毒症诱导的凝血功能障碍：可溶性 C 型凝集素样受体 2（sCLEC-2）水平与血小板计数的比值。
Platelets. 2022 Aug 18;33(6):935-944. doi: 10.1080/09537104.2021.2019694. Epub 2022 Jan 24.
6
Diagnostic and prognostic value of Sepsis-Induced coagulopathy and International Society on Thrombosis and Hemostasis scoring systems in COVID-19-associated disseminated intravascular coagulopathy.脓毒症诱导的凝血病及国际血栓与止血协会评分系统在新型冠状病毒肺炎相关弥散性血管内凝血中的诊断和预后价值
J Res Med Sci. 2021 Oct 18;26:102. doi: 10.4103/jrms.JRMS_1295_20. eCollection 2021.
7
Soluble C-Type Lectin-Like Receptor 2 Is a Biomarker for Disseminated Intravascular Coagulation.可溶性C型凝集素样受体2是弥散性血管内凝血的生物标志物。
J Clin Med. 2021 Jun 28;10(13):2860. doi: 10.3390/jcm10132860.
8
Disseminated intravascular coagulation: epidemiology, biomarkers, and management.弥散性血管内凝血：流行病学、生物标志物和治疗。
Br J Haematol. 2021 Mar;192(5):803-818. doi: 10.1111/bjh.17172. Epub 2021 Feb 8.
9
Sepsis-Induced Coagulopathy and Disseminated Intravascular Coagulation.脓毒症相关性凝血障碍与弥散性血管内凝血。
Semin Thromb Hemost. 2020 Feb;46(1):89-95. doi: 10.1055/s-0039-1694995. Epub 2019 Aug 23.
10
Soluble CLEC-2 is generated independently of ADAM10 and is increased in plasma in acute coronary syndrome: comparison with soluble GPVI.可溶性 CLEC-2 独立于 ADAM10 产生，并在急性冠状动脉综合征的血浆中增加：与可溶性 GPVI 的比较。
Int J Hematol. 2019 Sep;110(3):285-294. doi: 10.1007/s12185-019-02680-4. Epub 2019 Jun 5.
Zotero 插件